Hypertensive myocardial fibrosis

被引：72

作者：

Cuspidi, C

Ciulla, M

Zanchetti, A

机构：

[1] Univ Milan, Osped Maggiore Policlin, IRCCS, Ctr Interuniv Fisiol Clin & Ipertens, I-20122 Milan, Italy

[2] Univ Milan, Osped Maggiore Policlin, IRCCS, Ist Med Cardiovascolare, I-20122 Milan, Italy

[3] IRCCS, Ist Auxol Italiano, Milan, Italy

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷 / 01期

关键词：

fibrosis; hypertension; left ventricular hypertrophy;

D O I：

10.1093/ndt/gfi237

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：20 / 23

页数：5

共 30 条

[1]

AMANUMA S, 1994, POSTGRAD MED J, V70, pS67

[2] Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease [J].

Brilla, CG ;

Funck, RC ;

Rupp, H .

CIRCULATION, 2000, 102 (12) :1388-1393

[3] Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs [J].

Brilla, CG .

CARDIOVASCULAR RESEARCH, 2000, 46 (02) :324-331

[4] TEMPORAL DIFFERENCES IN FIBROBLAST PROLIFERATION AND PHENOTYPE EXPRESSION IN RESPONSE TO CHRONIC ADMINISTRATION OF ANGIOTENSIN-II OR ALDOSTERONE [J].

CAMPBELL, SE ;

JANICKI, JS ;

WEBER, KT .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (08) :1545-1560

[5] VALUE OF ECHOCARDIOGRAPHIC MEASUREMENT OF LEFT-VENTRICULAR MASS IN PREDICTING CARDIOVASCULAR MORBID EVENTS IN HYPERTENSIVE MEN [J].

CASALE, PN ;

DEVEREUX, RB ;

MILNER, M ;

ZULLO, G ;

HARSHFIELD, GA ;

PICKERING, TG ;

LARAGH, JH .

ANNALS OF INTERNAL MEDICINE, 1986, 105 (02) :173-178

[6] Echocardiographic patterns of myocardial fibrosis in hypertensive patients: Endomyocardial biopsy versus ultrasonic tissue characterization [J].

Ciulla, M ;

Paliotti, R ;

Hess, DB ;

Tjahja, E ;

Campbell, SE ;

Magrini, F ;

Weber, KT .

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 1997, 10 (06) :657-664

[7]

Ciulla M, 1997, ADV EXP MED BIOL, V432, P45

[8] Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis -: Results of a randomized trial [J].

Ciulla, MM ;

Paliotti, R ;

Esposito, A ;

Diez, J ;

López, BA ;

Dahlóf, B ;

Nicholls, G ;

Smith, RD ;

Gilles, L ;

Magrini, F ;

Zanchetti, A .

CIRCULATION, 2004, 110 (05) :552-557

[9] Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey [J].

Cuspidi, C ;

Ambrosioni, E ;

Mancia, G ;

Pessina, AC ;

Trimarco, B ;

Zanchetti, A .

JOURNAL OF HYPERTENSION, 2002, 20 (07) :1307-1314

[10] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

← 1 2 3 →